Real-world outcomes and complications of different surgical approaches for significant submacular haemorrhages

Indian J Ophthalmol. 2023 May;71(5):2045-2052. doi: 10.4103/ijo.IJO_1987_22.

Abstract

Purpose: To evaluate the outcomes and complications after different surgical management of cases with significant sumacular hemorrhage (SMH) of size more than 4 disc diameter (DD).

Methods: It was a retrospective interventional study. All consecutive 103 cases of significant SMHs were treated by vitrectomy and divided into three groups. In Group A (<4 weeks, confined to the macula or extending inferiorly, n = 62), vitrectomy, subretinal cocktail of tissue plasminogen activator (tPA), antivascular endothelial growth factor, and air with SF6 gas; in Group B (4-8 weeks, extending beyond macula, n = 31), subretinal tPA followed by SMH drainage either by retinotomy (Group B-1, n = 17) or by temporal 180-degree retinectomy (Group B-2, n = 14) with silicone oil (SO) tamponade; and in Group C (>8 weeks, extending beyond macula, n = 10), SMH removal with autologous retinal pigment epithelium (RPE)-Choroid patch graft transplantations with SO tamponade were performed. Parameters evaluated were best corrected visual acuity (BCVA), Optos, optical computerized tomography, and ultrasonography as required.

Results: Significant visual improvement was seen from mean preoperative to mean postoperative BCVA in Group A (P < 0.001), Group B (P < 0.001), and Group C (P < 0.001). Postoperative complications were recurrent SMH (4.84% vs 12.90% vs 10%), vitreous hemorrhage (6.45%, GroupA), hyphema (4.84% vs 12.90% vs 10%), hypotony (nil vs 3.23% vs 20%), macular hole formation (6.45%, Group A), epiretinal membrane (16.13%, Group B), and retinal detachment (3.23%, Group A and 10%, Group C).

Conclusion: Surgical approaches for significant submacular hemorrhage are visually awarding, though certain specific complications may arise.

Keywords: 180-degree retinectomy; autologous RPE-choroid patch graft transplantations; submacular hemorrhage; subretinal rt-plasminogen activator (PA).

MeSH terms

  • Fibrinolytic Agents* / therapeutic use
  • Humans
  • Retinal Hemorrhage / diagnosis
  • Retinal Hemorrhage / etiology
  • Retinal Hemorrhage / surgery
  • Retrospective Studies
  • Tissue Plasminogen Activator*
  • Treatment Outcome
  • Vitrectomy / methods

Substances

  • Tissue Plasminogen Activator
  • Fibrinolytic Agents